Merit Medical Systems Inc (MMSI) financials

NASDAQ · Health Care

$86.24 -7.66% Close Oct 30, 2026 Live

Merit Medical Systems revenue and earnings by year

Merit Medical Systems's revenue was $1.52 billion in the fiscal year to December 31, 2025, up 11.8% from the year before. Net income was $128 million, 8.5% of revenue. Since the fiscal year to December 31, 2016, revenue has grown 10.8% a year on average.

RevenueNet income
$0$500M$1.00B$1.50B
2016201720182019202020212022202320242025

Fiscal years, each labelled by the calendar year it ended in.

Income statement, the last 10 fiscal years

In billions of US dollars except per-share figures. Each column is a fiscal year, named by the month it ended.
Fiscal year toDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
Revenue1.521.361.261.151.070.960.990.880.730.60
Revenue growth11.8%7.9%9.2%7.1%11.5%-3.1%12.7%21.3%20.5%—
Gross profit0.740.640.580.520.490.400.430.390.330.27
Gross margin48.7%47.4%46.4%45.1%45.2%41.6%43.5%44.7%44.8%43.9%
Operating income0.180.160.120.090.06-0.000.020.060.030.03
Operating margin12.2%11.5%9.9%7.6%5.7%-0.2%1.6%6.6%4.5%5.8%
Net income0.130.120.090.070.05-0.010.010.040.030.02
Net margin8.5%8.9%7.5%6.5%4.5%-1.0%0.5%4.8%3.8%3.3%
Diluted EPS$2.13$2.03$1.62$1.29$0.84-$0.18$0.09$0.77$0.57$0.45
Free cash flow0.220.190.110.070.120.120.000.020.020.02

Diluted EPS is stated in today's shares (adjusted for every split since). Quarterly statements and the income statement as a flow chart are in the app: open MMSI in Markets.

How Merit Medical Systems makes money

Revenue by segment in the quarter to September 30, 2026, as the company reports it.

SegmentRevenueShare
Foundational Access$158M37.9%
Therapeutic$141M33.8%
Foundational Original Equipment Manufacturer$46.3M11.1%
Foundational Vascular Intervention$42.4M10.2%
Foundational Procedural Solutions$27.2M6.5%
Product & Service Other$2.01M0.5%

See also: MMSI valuation and P/E history · MMSI returns

No forecast, no recommendation. This page describes Merit Medical Systems Inc from published data; it is not advice to buy, sell or hold any security.

Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.